Aphria Inc
(Toronto Stock Exchange : APHA)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
ICPTIntercept Pharmaceuticals, Inc.
1.99%93.6618.6%$137.22m
AMRNAmarin Corporation Plc Sponsored ADR
11.99%19.522.0%$116.68m
SAGESAGE Therapeutics, Inc.
3.37%151.119.5%$74.30m
JAZZJazz Pharmaceuticals Plc
1.11%126.602.2%$72.77m
PRGOPerrigo Co. Plc
1.15%48.886.8%$61.55m
GWPHGW Pharmaceuticals PLC Sponsored ADR
5.17%151.406.3%$59.71m
CTLTCatalent Inc
1.32%43.102.4%$42.83m
PTLAPortola Pharmaceuticals, Inc.
2.36%30.867.7%$42.60m
ICLRICON Plc
1.93%144.904.1%$35.43m
CORTCorcept Therapeutics Incorporated.
4.42%11.585.5%$30.87m
HZNPHorizon Pharma plc
0.52%21.357.4%$29.78m
UTHRUnited Therapeutics Corporation
0.19%117.2514.4%$29.17m
MDCOMedicines Company
2.22%24.4321.8%$27.75m
AERIAerie Pharmaceuticals, Inc.
2.61%39.716.9%$27.21m
MNKMallinckrodt Plc
3.56%21.2521.1%$25.31m

Company Profile

Aphria, Inc. engages in the production and supply of medical cannabis. Its products include cannabis capsules, oral solutions, concentrate syringes and tetrahydrocannabinol and cannabidiol vaporizers. The company was founded by Cole Cacciavillani and John Cervini on June 22, 2011 and is headquartered in Leamington, Canada.